0001209191-11-052181.txt : 20111019 0001209191-11-052181.hdr.sgml : 20111019 20111019160827 ACCESSION NUMBER: 0001209191-11-052181 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111017 FILED AS OF DATE: 20111019 DATE AS OF CHANGE: 20111019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANADYS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001128495 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223193172 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5871 OBERLIN DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585303600 MAIL ADDRESS: STREET 1: 5871 OBERLIN DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QVT Fund LP CENTRAL INDEX KEY: 0001290165 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50632 FILM NUMBER: 111148221 BUSINESS ADDRESS: STREET 1: WALKERS SPV, WALKERS HOUSE STREET 2: P.O. BOX 908GT, MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 BUSINESS PHONE: 212-705-8800 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QVT Associates GP LLC CENTRAL INDEX KEY: 0001290166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50632 FILM NUMBER: 111148222 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-705-8800 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 c23468_4x0.xml MAIN DOCUMENT DESCRIPTION X0304 4 2011-10-17 0001128495 ANADYS PHARMACEUTICALS INC ANDS 0001290166 QVT Associates GP LLC 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 0 0 1 0 0001290165 QVT Fund LP WALKER HOUSE 87 MARY STREET GEORGE TOWN E9 Ky1-9005 CAYMAN ISLANDS 0 0 1 0 Common Stock, $0.001 par value 2011-10-17 4 S 0 650100 3.68 D 10770554 I Through QVT Fund LP and Quintessence Fund L.P. On October 17, 2011, QVT Fund LP sold 586,287 shares of Common Stock and Quintessence Fund L.P. sold 63,813 shares of Common Stock. As a result, QVT Fund LP directly beneficially owns 9,713,359 shares of Common Stock and Quintessence Fund L.P. directly beneficially owns 1,057,195 shares of Common Stock. QVT Associates GP LLC, as General Partner of QVT Fund LP and Quintessence Fund L.P., may be deemed to beneficially own the aggregate number of shares of Common Stock owned by QVT Fund LP and Quintessence Fund L.P. and accordingly, QVT Associates GP LLC may be deemed to be the indirect beneficial owner of an aggregate amount of 10,770,554 shares of Common Stock. /s/ Tracy Fu, Managing Member 2011-10-19